Table 1.
Demographics and clinical characteristics in patients with pruritic external auditory canal.
| Topical Calcineurine Inhibitor Group (n = 20, 39 Ears) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subject | Age | Sex | Laterality | Culture | Total Ig E | MAST | Underlying Disease |
Previous Itchy Ear Treatment |
Intial VAS (R) |
Intial VAS (L) |
P2W VAS (R) |
P2W VAS (L) | P1M VAS (R) |
P1M VAS (L) | P2M VAS (R) |
P2M VAS (L) |
| 1 | 69 | M | B | NG | 40.8 | Negative | HTN | Steroid otic drop | 10 | 10 | 5 | 5 | 2 | 2 | 2 | 2 |
| 2 | 46 | M | B | NG | 961 | DF (class 2), Cladosporium (class 1) |
Angina | Antihistamine (oral) | 7 | 4 | 1 | 1 | 0 | 0 | 0 | 0 |
| 3 | 65 | M | B | NG | 20.5 | DF (class1) |
- | Steroid otic drop | 4 | 6 | 4 | 6 | 6 | 7 | 7 | 7 |
| 4 | 64 | F | B | NG | 17 | Negative | HTN | - | 10 | 10 | 3 | 3 | 1 | 1 | 2 | 1 |
| 5 | 81 | M | B | NG | <2 | Negative | Angina | Vinegar irrigation | 5 | 5 | 2 | 2 | 2 | 2 | 2 | 2 |
| 6 | 90 | M | L | NG | 7.63 | Negative | HTN, BPH | - | 0 | 7 | 0 | 6 | 0 | 6 | 0 | 6 |
| 7 | 80 | F | B | NG | 21.7 | Negative | Dementia | - | 8 | 10 | 2 | 1 | 2 | 1 | 2 | 1 |
| 8 | 85 | F | B | NG | 12.3 | Negative | - | Antibiotics Otic drop |
8 | 5 | 5 | 3 | 3 | 3 | 2 | 2 |
| 9 | 74 | M | B | NG | 236 | Negative | - | - | 6 | 6 | 2 | 1 | 1 | 1 | 0 | 0 |
| 10 | 49 | F | B | NG | 42.8 | DP (class 1) |
- | - | 5 | 5 | 3 | 3 | 0 | 0 | 0 | 0 |
| 11 | 68 | M | B | NG | 84.9 | Negative | HTN, Arrythmia | Topical steroid oint | 10 | 10 | 1 | 1 | 3 | 3 | 2 | 2 |
| 12 | 52 | F | B | NG | 130 | Positive control > 100 | - | - | 6 | 2 | 2 | 0 | 6 | 1 | 6 | 1 |
| 13 | 61 | F | B | NG | 393 | DP/DF (class 2/3) |
HTN | - | 5 | 8 | 3 | 6 | 2 | 2 | 2 | 2 |
| 14 | 57 | F | B | NG | 36 | Negative | HTN | Topical steroid oint | 10 | 10 | 3 | 3 | 4 | 4 | 7 | 7 |
| 15 | 64 | F | B | NG | <2 | Positive control > 100 | HTN, DM (on insulin) | - | 8 | 5 | 5 | 0 | 5 | 0 | 5 | 0 |
| 16 | 78 | M | B | NG | 1160 | DF (class 2) |
HTN | - | 5 | 5 | 2 | 2 | 2 | 2 | 2 | 2 |
| 17 | 45 | F | B | NG | 22.3 | Negative | HTN | Antihistamine (oral) | 8 | 7 | 2 | 1 | 1 | 2 | 1 | 1 |
| 18 | 79 | F | B | NG | 31.8 | Japanese hop (class 1) |
HTN | - | 6 | 6 | 2 | 2 | 3 | 3 | 3 | 3 |
| 19 | 78 | M | B | NG | 10 | Negative | BPH | Topical steroid oint | 10 | 10 | 8 | 8 | 10 | 10 | 10 | 10 |
| 20 | 71 | M | B | NG | 160.7 | Negative | HTN | Vinegar irrigation | 6 | 6 | 4 | 3 | 4 | 3 | 3 | 2 |
| Topical moisturizing cream group (n = 19, 34 ears) | ||||||||||||||||
| Subject | Age | Sex | Laterality | Culture | Total Ig E | MAST |
Underlying
disease |
Previous
itchy ear treatment |
intial VAS
(Rt.) |
intial VAS
(Lt.) |
P2W VAS
(Rt.) |
P2W VAS (Lt.) |
P1M VAS
(Rt.) |
P1M VAS (Lt.) |
P2M VAS
(Rt.) |
P2M VAS
(Lt.) |
| 1 | 54 | M | L | NG | 39.1 | Negative | HTN, DM (on insulin) |
Antihistamine (oral) | NA | 9 | 0 | 3 | 0 | 4 | 0 | 4 |
| 2 | 63 | F | B | NG | 23.9 | Negative | Ovarian cancer | - | 5 | 7 | 2 | 5 | 1 | 2 | 1 | 2 |
| 3 | 82 | M | B | NG | <2 | Negative | HTN | Steroid otic drop | 9 | 1 | 9 | 1 | 9 | 1 | 9 | 1 |
| 4 | 58 | F | L | NG | 4.84 | Negative | - | - | 0 | 6 | 0 | 5 | 0 | 0 | 0 | 0 |
| 5 | 55 | F | B | NG | 10.8 | DF (class 1) | - | - | 5 | 5 | 3 | 3 | 2 | 2 | 1 | 1 |
| 6 | 69 | F | B | NG | 53.2 | Negative | - | Topical steroid oint | 3 | 3 | 1 | 1 | 0 | 0 | 0 | 0 |
| 7 | 31 | M | B | NG | 102 | cat (class 4) dog (class 2) |
- | Antibiotics otic drop Antihistamine (oral) |
7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 8 | 64 | F | B | NG | 115 | DP/DF (class 1/1) | - | Steroid otic drop | 10 | 10 | 4 | 4 | 6 | 6 | 6 | 6 |
| 9 | 63 | F | B | NG | 94.3 | Negative | - | - | 5 | 5 | 3 | 3 | 1 | 1 | 1 | 1 |
| 10 | 69 | M | B | NG | <2 | Negative | HTN | Vinegar irrigation | 2 | 4 | 1 | 3 | 1 | 1 | 1 | 1 |
| 11 | 55 | F | B | NG | 18.3 | Negative | HTN | - | 5 | 5 | 2 | 2 | 4 | 4 | 4 | 4 |
| 12 | 64 | F | R | NG | 9.97 | Negative | HTN | Topical steroid oint | 8 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
| 13 | 63 | F | B | NG | 85.1 | Negative | HTN | - | 4 | 8 | 3 | 5 | 3 | 4 | 2 | 2 |
| 14 | 59 | F | R | NG | 59.7 | Negative | - | Topical steroid oint | 8 | 0 | 5 | 0 | 6 | 0 | 6 | 0 |
| 15 | 70 | F | B | NG | 3.32 | Negative | - | 2 | 7 | 0 | 4 | 0 | 1 | 0 | 0 | |
| 16 | 75 | F | B | NG | 21.8 | Negative | - | Steroid otic drop | 6 | 6 | 4 | 4 | 3 | 3 | 2 | 2 |
| 17 | 57 | F | B | NG | 29 | Negative | - | - | 3 | 6 | 1 | 3 | 1 | 3 | 1 | 3 |
| 18 | 80 | M | B | NG | 83.9 | Negative | HTN, BPH, Angina | - | 4 | 8 | 3 | 7 | 1 | 1 | 1 | 2 |
| 19 | 69 | F | B | NG | 19.5 | DP/DF (class 1/1) |
HTN | Vinegar irrigation Antihistamine (oral) |
7 | 9 | 1 | 3 | 1 | 3 | 1 | 3 |
Abbreviation: M, male; F, female; R, right; L, left; B, both; NG, no growth; Ig E, Immunoglobulin E; MAST, multiple allergen simultaneous test; VAS, visual analog scale; HTN, hypertension; DM, diabetes mellitus; BPH, benign prostate hyperplasia; P2W, postoperative 2 weeks; P1M, postoperative 1 month; P2M, postoperative 2 months.